Pinnacle Awards Nomination Requirements

Pinnacle Awards Nomination Requirements

The Pinnacle Awards recognize the accomplishments of individuals; groups of individuals; and health care organizations, corporations, and nonprofit organizations as well as government and voluntary health agencies that have had a positive impact on the medication use process and the delivery of pharmaceutical care.
Pinnacle Awards Selection Criteria
Special emphasis will be placed on:
   1) submissions that improve patient adherence to prescribed medication therapies and
   2) programs that promote the use of and adherence to national treatment guidelines.
Selection Process
Award selections are approved by the APhA Foundation Board of Directors on the basis of careful review of the recommendations of a Selection Committee. Upon receipt of nominations, APhA Foundation staff review submissions for completeness and compliance with guidelines. If acceptable, staff will forward the nominations to the APhA Foundation Selection Committee. Incomplete nominations will be returned.
Awards are given in 3 categories:

Category I

Individual Award for Career Achievement

Nominees in the Career Achievement category are individuals who by their actions have demonstrated exceptional leadership in enhancing quality in health care and medication use. The award recipient must have engaged in efforts to do the following:

  • Promote quality health care and catalyze advances in the betterment of medication use.
  • Cultivate, in professional and personal life, a commitment to quality in health care to increase the well-being of people.
  • Lead in implementing improvements in medication use and overall health care quality, especially in the areas of improving medication adherence and/or developing or implementing national treatment guidelines or evidence-based medicine.

Category II

Group Practices, Health Systems, Health Care Corporations

This category recognizes a significant scientific contribution and/or quality improvement project conducted in one or more of the following areas:

  • Fostering the role of multidisciplinary health care teams in improving medication persistence and adherence.
  • Adoption of, or adherence to, national treatment guidelines.
  • Preventing and eliminating adverse drug events.
  • Developing innovations and improvement techniques to enhance medication use.
  • Innovation in the management of drug therapy while significantly improving patient outcomes.

Category III

Voluntary Health Agencies, Nonprofit Organizations, Associations, Government Agencies, and Public/Private Partnerships

Special emphasis in this category is placed on submissions that assist patients and their caregivers in achieving better outcomes from their medications. Examples include patient education initiatives; new health care delivery models in which the patient and/or caregiver figures prominently; programs that promote patient understanding, improve adherence to drug therapy, or prevent or eliminate adverse drug events; and partnerships between public and private entities to improve patient outcomes.